An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 212670
Company: STRIDES PHARMA

Products on ANDA 212670

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ZILEUTON	ZILEUTON	600MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 212670

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/16/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 212670

ZILEUTON

TABLET, EXTENDED RELEASE;ORAL; 600MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ZILEUTON	ZILEUTON	600MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	211390	AIZANT
ZILEUTON	ZILEUTON	600MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215742	ANNORA PHARMA
ZILEUTON	ZILEUTON	600MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	204929	RISING
ZILEUTON	ZILEUTON	600MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	212670	STRIDES PHARMA

Top